Summary
Updated Aug 30, 2026
Jay Shepard is Director of Esperion Therapeutics, Inc. (ESPR). 5 SEC Form 4 filings on record going back to 2025, most recently on 13 July 2026.
Recent Transactions
4Every recent SEC Form 4 transaction Jay Shepard has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Jay Shepard files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Alexander J. Denner - $20.53M of IRWD open-market activity in the last 12 months
- Ronald Silver - $831K of IRWD open-market activity in the last 12 months
- Thomas A. McCourt - $740K of IRWD open-market activity in the last 12 months
- Sheldon L. Koenig - $318K of ESPR open-market activity in the last 12 months
- Minardo John - $136K of IRWD open-market activity in the last 12 months
- Michael Shetzline - $122K of IRWD open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Jay Shepard?
Jay Shepard is a corporate insider, tracked as Director of Esperion Therapeutics, Inc. (ESPR). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Jay Shepard submitted recently?
3 primary Form 4 filings in the last 90 days, covering 2 companies.
Where can I see all of Jay Shepard's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Jay Shepard and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
